Charles River Laboratories International (CRL) Divestments (2010 - 2025)

Charles River Laboratories International (CRL) posted quarterly Divestments of $17.4 million for Q1 2025, down 75.93% quarter-over-quarter from $72.5 million in Q2 2017.

Charles River Laboratories International (CRL) Divestments (2010 - 2025) Analysis & Trends

Charles River Laboratories International's Divestments history runs 3 years deep, the most recent figure standing at $17.4 million for Q1 2025.

  • In Q1 2025, Divestments changed N/A year-over-year to $17.4 million; the TTM figure through Dec 2025 stood at $17.4 million (changed N/A YoY), while the FY2025 annual figure was $17.4 million, changed N/A from the prior year.
  • Divestments for Q1 2025 stood at $17.4 million, down from $72.5 million in the prior quarter.
  • The five-year high for Divestments was $17.4 million in Q1 2025, with the low at $17.4 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn -
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn -
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn -
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn -
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn -
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn -
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn -
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn -
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn -
10 Charles River Laboratories International 12.89 Bn 12.68 Bn 1.81 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2025 17.44 Mn
Apr 1, 2017 72.46 Mn
Dec 25, 2010 8,000.00
Sep 25, 2010 5,000.00
Jun 26, 2010 961,000.00
Mar 27, 2010 1.83 Mn